![]() terameprocol structure
|
Common Name | terameprocol | ||
---|---|---|---|---|
CAS Number | 24150-24-1 | Molecular Weight | 358.471 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 458.5±40.0 °C at 760 mmHg | |
Molecular Formula | C22H30O4 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 108.8±34.2 °C | |
Symbol |
![]() GHS09 |
Signal Word | Warning |
Use of terameprocolTerameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3]. |
Name | meso-tetra-O-methyl nordihydroguaiaretic acid |
---|---|
Synonym | More Synonyms |
Description | Terameprocol is a synthetic derivative of Nordihydroguaiaretic acid and a non-selective lipoxygenase inhibitor. Terameprocol has antiviral and antitumor effects[1][2][3]. |
---|---|
Related Catalog | |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 458.5±40.0 °C at 760 mmHg |
Molecular Formula | C22H30O4 |
Molecular Weight | 358.471 |
Flash Point | 108.8±34.2 °C |
Exact Mass | 358.214417 |
PSA | 36.92000 |
LogP | 5.86 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.522 |
Terameprocol, a novel site-specific transcription inhibitor with anticancer activity.
Drugs 3rd ed., 11 , 204-214, (2008) Terameprocol, a novel, semisynthetic derivative of a naturally occurring plant lignan, is under development by Erimos Pharmaceuticals LLC for the potential treatment of cancer. The antitumor activity ... |
|
Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01.
PLoS ONE 11 , e0148685, (2016) The ability of Tetra-O-methyl nordihydroguaiaretic acid (M4N) to induce rapid cell death in combination with Etoposide, Rapamycin, or UCN-01 was examined in LNCaP cells, both in cell culture and anima... |
|
Synthesis of apolipoprotein B lipoparticles to deliver hydrophobic/amphiphilic materials.
ACS Appl. Mater. Interfaces 5 , 7509-16, (2013) To develop a drug delivery system (DDS), it is critical to address challenging tasks such as the delivery of hydrophobic and amphiphilic compounds, cell uptake, and the metabolic fate of the drug deli... |
terameprocol |
tetramethyl Nordihydroguaiaretic Acid Exclusive |
4-[(2R,3S)-4-(3,4-Dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene |
tetramethyl Nordihydroguaiaretic Acid |
Benzene, 4-[(2R,3S)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxy- |